Vaxcyte (PCVX)
Developer of high-valency bacterial vaccine candidates using cell-free protein synthesis.
$57.86
vs last close−1.16 (−1.97%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 113.24% | 168.51M shares | |
|---|---|---|---|
| 351 holders · as of Jun 30, 2026 | |||
| Insiders | 0.86% | 1.28M shares | |
| 15 holders · as of Sep 9, 2026 | |||
| Strategic holders | 11.14% | 16.58M shares | |
| 1 holder · as of May 15, 2026 | |||
| Adds to | 125.24% | ||
148.81M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 125.24%; nothing is left for Other.
13F, as of Jun 30, 2026
351 holders · 168.51M shares · 51 new positions · 186 increased · 101 reduced · 55 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 20.85M | 14.01% | +4.36M | Aug 13, 2026 |
| Jupiter Topco LLC | 17.97M | 12.07% | +17.97Mnew | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | 12.21M | 8.20% | +81.4K | Aug 14, 2026 |
| BlackRock, Inc. | 12.07M | 8.11% | +1.10M | Aug 7, 2026 |
| Ra Capital Management, L.P. | 11.47M | 7.71% | 0 | Aug 14, 2026 |
| Wellington Management Group LLP | 7.00M | 4.71% | +1.39M | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 6.59M | 4.43% | +314.0K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 6.35M | 4.27% | +82.0K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Janus Henderson Group PLC | 11.50% | 16.58M | 13G | May 15, 2026 |
| FMR LLC | 11.40% | 16.45M | 13G | May 6, 2026 |
| RA Capital Management, L.P. | 8.90% | 12.97M | 13G | May 15, 2026 |
| T. Rowe Price Investment Management, Inc. | 8.60% | 11.30M | 13G | Feb 17, 2026 |
| BlackRock, Inc. | 7.60% | 9.83M | 13G | Apr 17, 2025 |
| Vanguard Capital Management | 5.03% | 7.25M | 13G | Apr 30, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 9, 2026 | Jim Wassilofficer: EVP, Chief Scientific Ofc, COO | Sale | 1,334 | $59.52 | 145,435 |
| Sep 4, 2026 | Jim Wassilofficer: EVP, Chief Scientific Ofc, COO | Sale | 1,381 | $61.16 | 152,228 |
| Sep 1, 2026 | Jim Wassilofficer: CHIEF OPERATING OFFICER | Sale · 4 lots | 3,477 | $61.07 | 155,041 |
| Aug 3, 2026 | Andrew Guggenhimeofficer: PRESIDENT AND CFO | Sale · 2 lots | 10,000 | $53.89 | 105,176 |
| Aug 3, 2026 | Jim Wassilofficer: CHIEF OPERATING OFFICER | Sale · 2 lots | 2,250 | $53.86 | 157,541 |
| Aug 5, 2026 | Harpreet S. Dhaliwalofficer: Chief Technical Ops Officer | Sale | 17,000 | $55.00 | 76,756 |
| Jul 27, 2026 | Grant Pickeringdirector, officer: CHIEF EXECUTIVE OFFICER | Sale · 6 lots | 18,198 | $55.63 | 586,462 |
| Jul 1, 2026 | Jim Wassilofficer: CHIEF OPERATING OFFICER | Sale · 3 lots | 2,250 | $56.33 | 156,760 |
| Jul 6, 2026 | Andrew Guggenhimeofficer: PRESIDENT AND CFO | Sale · 2 lots | 10,000 | $57.28 | 104,395 |
| Jun 26, 2026 | Grant Pickeringdirector, officer: CHIEF EXECUTIVE OFFICER | Sale · 9 lots | 24,237 | $55.22 | 586,681 |
House and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Gilbert Cisneros · CA31 | Purchase | $1,001 – $15,000 | Jul 16, 2026 | Sep 7, 2026 | |
| Rep. Gilbert Ray Cisneros · CA31 | Purchase | $1,001 – $15,000 | Jul 16, 2026 | Sep 7, 2026 | |
| Rep. Gilbert Ray Cisneros · CA31 | Purchase | $1,001 – $15,000 | Jul 15, 2026 | Sep 7, 2026 | |
| Rep. Gilbert Cisneros · CA31 | Purchase | $1,001 – $15,000 | May 13, 2026 | Jun 9, 2026 | |
| Rep. Gilbert Cisneros · CA31 | Purchase | $1,001 – $15,000 | May 12, 2026 | Jun 9, 2026 |